Published in Infect Immun on August 01, 2002
Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A (2006) 1.64
Shiga toxin subtypes display dramatic differences in potency. Infect Immun (2011) 1.63
Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect Immun (2003) 1.55
Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun (2004) 1.03
Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines. Infect Immun (2004) 1.03
Induction of apoptosis by Shiga toxins. Future Microbiol (2010) 1.02
Inhibition of apoptosis by Escherichia coli K1 is accompanied by increased expression of BclXL and blockade of mitochondrial cytochrome c release in macrophages. Infect Immun (2004) 1.00
Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells. Biochem J (2004) 0.97
Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect Immun (2003) 0.97
Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect Immun (2006) 0.86
Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit gamma interferon-mediated cellular activation. Infect Immun (2012) 0.86
Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells. Infect Immun (2004) 0.83
An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo. Mol Cancer (2010) 0.80
Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by Shiga toxin type 1. Infect Immun (2010) 0.79
Soluble products of Escherichia coli induce mitochondrial dysfunction-related sperm membrane lipid peroxidation which is prevented by lactobacilli. PLoS One (2013) 0.79
Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector. Cell Adh Migr (2014) 0.76
Impairment by sperm agglutinating factor isolated from Escherichia coli: receptor specific interactions. Biomed Res Int (2013) 0.76
SLT-VEGF reduces lung metastases, decreases tumor recurrence, and improves survival in an orthotopic melanoma model. Toxins (Basel) (2010) 0.75
Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease. Front Cell Infect Microbiol (2016) 0.75
Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin. FEBS Open Bio (2015) 0.75
Caspases: enemies within. Science (1998) 19.45
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell (1998) 13.87
Caspases: the executioners of apoptosis. Biochem J (1997) 11.99
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev (2000) 8.35
Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol (1999) 8.21
BID: a novel BH3 domain-only death agonist. Genes Dev (1996) 5.90
Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol (2000) 5.85
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun (1991) 4.63
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev (1998) 3.92
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli. J Clin Invest (2001) 2.80
A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol (2000) 2.72
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65
The machinery of programmed cell death. Pharmacol Ther (2001) 2.58
The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol (1999) 2.50
Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21. Infect Immun (1994) 2.37
The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol (1995) 2.32
Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun (1990) 2.32
Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci (1999) 2.25
Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol (1997) 2.07
Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells. Gastroenterology (2000) 2.07
Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene (2001) 1.91
Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem (1989) 1.88
Reproduction of edema disease of swine with purified Shiga-like toxin-II variant. Vet Pathol (1991) 1.85
Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int (2000) 1.77
Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med (1999) 1.71
Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect (2001) 1.63
Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res (2001) 1.57
Shiga toxins. Toxicon (2001) 1.54
Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun (2001) 1.49
Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A (1992) 1.43
Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol (2000) 1.37
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35
Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem (2000) 1.21
Programmed cell death in infectious diseases. Trends Microbiol (1993) 1.18
Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis (1994) 1.17
Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am J Physiol (1998) 1.10
Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J Infect Dis (1998) 1.06
Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J Neurooncol (1998) 1.04
Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int (1998) 1.02
Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. Biochim Biophys Acta (1999) 0.97
Many cell types are Shiga toxin targets. Kidney Int (2000) 0.92
Activation of the caspase cascade during Stx1-induced apoptosis in Burkitt's lymphoma cells. J Cell Biochem (2001) 0.89
Shiga toxins induce apoptosis in pulmonary epithelium-derived cells. J Infect Dis (1999) 0.88
Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome. Nephron (2001) 0.87
Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3). Int J Biol Macromol (1995) 0.86
Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs. Can J Vet Res (1998) 0.81
Verocytotoxins (Shiga-like toxins) produced by Escherichia coli: a minireview of their classification, clinical presentations and management of a heterogeneous family of cytotoxins. Comp Immunol Microbiol Infect Dis (1999) 0.80
Analysis of interactions between glycosphingolipids and microbial toxins. Methods Enzymol (2000) 0.79
Cytotoxin produced by Escherichia coli isolated from chickens with swollen head syndrome (SHS). Vet Microbiol (1998) 0.77
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol (2009) 5.83
Bacterial infection causes stress-induced memory dysfunction in mice. Gut (2010) 3.06
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr (2011) 1.95
Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol (2008) 1.84
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 1.81
The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2002) 1.75
The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity (2013) 1.71
Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut (2007) 1.69
Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology (2002) 1.68
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol (2006) 1.52
Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis (2006) 1.52
A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci U S A (2005) 1.45
Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy (2009) 1.45
Scurvy diagnosed in a pediatric liver transplant patient awaiting combined kidney and liver retransplantation. Pediatr Transplant (2008) 1.42
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. J Infect Dis (2004) 1.40
Notice: the importance of adhering to The Journal's Guide for Authors. J Pediatr (2010) 1.39
Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci (2004) 1.37
Setting research priorities to reduce mortality and morbidity of childhood diarrhoeal disease in the next 15 years. PLoS Med (2013) 1.34
Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell Microbiol (2006) 1.34
Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis (2005) 1.34
Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun (2003) 1.33
SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun (2005) 1.32
In silico genomic analyses reveal three distinct lineages of Escherichia coli O157:H7, one of which is associated with hyper-virulence. BMC Genomics (2009) 1.29
Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res (2009) 1.28
Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol (2003) 1.27
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis (2010) 1.22
Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics (2010) 1.21
JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90alpha and triggers signalling pathways leading to the activation of NF-kappaB and p38 MAP kinase in epithelial cells. Cell Microbiol (2003) 1.19
Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect (2007) 1.19
Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J Bacteriol (2008) 1.18
Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation. Can J Gastroenterol (2005) 1.17
Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology (2012) 1.12
Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect Immun (2004) 1.12
Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2002) 1.10
Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun (2005) 1.08
Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling. Microbiology (2010) 1.07
Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains. J Clin Microbiol (2005) 1.06
Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev (2007) 1.05
Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol (2004) 1.05
Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia. PLoS One (2009) 1.04
Rapid genoserotyping tool for classification of Salmonella serovars. J Clin Microbiol (2011) 1.04
Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun (2004) 1.03
Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease. Am J Physiol Gastrointest Liver Physiol (2004) 1.03
Cholesterol-enriched membrane microdomains are required for inducing host cell cytoskeleton rearrangements in response to attaching-effacing Escherichia coli. Infect Immun (2005) 0.98
Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol (2006) 0.98
Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol (2005) 0.98
Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One (2012) 0.98
Protein-tyrosine phosphatase sigma is associated with ulcerative colitis. Curr Biol (2007) 0.98
Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. FEMS Microbiol Lett (2009) 0.97
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology (2011) 0.97
Fascination with bacteria-triggered cell death: the significance of Fas-mediated apoptosis during bacterial infection in vivo. Microbes Infect (2003) 0.97
Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis (2010) 0.97
Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect Immun (2003) 0.97
Pathogenesis of Helicobacter pylori infection. Helicobacter (2013) 0.96
Autophagy as an emerging dimension to adaptive and innate immunity. Semin Immunol (2009) 0.96
Isolation and genetic characterization of a coinfection of non-O157 Shiga toxin-producing Escherichia coli. J Clin Microbiol (2007) 0.95
Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis (2012) 0.95
Interleukin-1 receptor phosphorylation activates Rho kinase to disrupt human gastric tight junctional claudin-4 during Helicobacter pylori infection. Cell Microbiol (2010) 0.93
Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol (2013) 0.92
The continuing evolution of a bacterial pathogen. Proc Natl Acad Sci U S A (2008) 0.92
Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect Immun (2002) 0.91
Applicability of phylogenetic methods for characterizing the public health significance of verocytotoxin-producing Escherichia coli strains. Appl Environ Microbiol (2007) 0.91
Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol (2009) 0.91
Dietary patterns and ethnicity are associated with distinct plasma proteomic groups. Am J Clin Nutr (2011) 0.89
Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon. Infect Immun (2006) 0.89
Helicobacter pylori infection and childhood. Helicobacter (2010) 0.88
Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans. Clin Vaccine Immunol (2011) 0.88
Recent advances in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol (2012) 0.88
What is new related to Helicobacter pylori infection in children and teenagers? Arch Pediatr Adolesc Med (2005) 0.88
S100 calgranulin proteins S100A8, S100A9 and S100A12 are expressed in the inflamed gastric mucosa of Helicobacter pylori-infected children. Can J Gastroenterol (2008) 0.87
Multiplexed high-throughput electrokinetically-controlled immunoassay for the detection of specific bacterial antibodies in human serum. Anal Chim Acta (2007) 0.87
Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect Immun (2006) 0.86
Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues. J Infect Dis (2004) 0.86
Development of a novel hand-held immunoassay for the detection of enterohemorrhagic Escherichia coli O157:H7. Biomed Microdevices (2004) 0.86
Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit gamma interferon-mediated cellular activation. Infect Immun (2012) 0.86
Helicobacter pylori infection and gastric cancer: host, bug, environment, or all three? Curr Gastroenterol Rep (2004) 0.86
The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations. Am J Gastroenterol (2010) 0.85
Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion. Pediatr Res (2008) 0.85
Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Oral microbiome composition changes in mouse models of colitis. J Gastroenterol Hepatol (2015) 0.85
Cytoskeletal rearrangements in gastric epithelial cells in response to Helicobacter pylori infection. J Med Microbiol (2003) 0.85
Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection. Can J Gastroenterol (2013) 0.84
Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections. Pediatr Nephrol (2002) 0.84
Development of a novel microfluidic immunoassay for the detection of Helicobacter pylori infection. Analyst (2004) 0.84
Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis. Gastroenterology (2011) 0.84
Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1. Microbiology (2009) 0.84
From diarrhea to obesity in prohormone convertase 1/3 deficiency: age-dependent clinical, pathologic, and enteroendocrine characteristics. J Clin Gastroenterol (2013) 0.83
Detergent-resistant microdomains mediate activation of host cell signaling in response to attaching-effacing bacteria. Lab Invest (2009) 0.83
An electrokinetically-controlled immunoassay for simultaneous detection of multiple microbial antigens. Biomed Microdevices (2005) 0.83
Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells. Infect Immun (2004) 0.83